Legato Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-62,027
| Closed | -$786K | – | 584 |
|
|
2024
Q4 | $786K | Sell |
62,027
-1,140
| -2% | -$14.4K | 0.1% | 343 |
|
|
2024
Q3 | $880K | Buy |
+63,167
| New | +$880K | 0.11% | 335 |
|
|
2024
Q2 | – | Sell |
-32,029
| Closed | -$529K | – | 576 |
|
|
2024
Q1 | $529K | Sell |
32,029
-9,889
| -24% | -$163K | 0.06% | 429 |
|
|
2023
Q4 | $612K | Buy |
41,918
+5,242
| +14% | +$76.5K | 0.08% | 374 |
|
|
2023
Q3 | $450K | Sell |
36,676
-7,012
| -16% | -$86K | 0.07% | 415 |
|
|
2023
Q2 | $522K | Buy |
43,688
+13,696
| +46% | +$164K | 0.07% | 413 |
|
|
2023
Q1 | $401K | Buy |
29,992
+6,218
| +26% | +$83.1K | 0.07% | 387 |
|
|
2022
Q4 | $512K | Buy |
+23,774
| New | +$512K | 0.1% | 348 |
|